Roche and Senseonics Expand Partnership
Roche announced it has expanded its partnership with Senseonics to integrate data from the Eversense CGM into Roche’s digital diabetes management solutions (mySugr app and Accu-Chek Smart Pix). According to the press release, the data integration will be available by early 2019. Interestingly, the press release does not discuss what geographies are covered in the partnership expansion. While the Roche/Senseonics commercial partnership is currently limited to Ex-US geographies (Europe, Middle East, and Africa), the expansion of their collaboration could suggest that a US partnership/acquisition is on the horizon. Below, FENIX provides thoughts on how Eversense data integration fits into both companies’ strategies.
About The Author
Matthew has been a thought leader in the high-growth therapeutic areas of diabetes and cardiovascular medicine since 2006, making regular attendance at large and small CV/met scientific meetings and an architect of novel methods for assessing market opportunities. He has over a decade of experience in leading CV/met consulting engagements, is a published author in PM360 and Diabetes Technology & Therapeutics, and has been quoted in The Pink Sheet on anti-thrombotics.
If you receive our email blasts, you already have an account. Log in now
You can read the article’s full content online after purchase.